Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin effects on social behavior and neural activity
NCT02394054Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Intranasal vasopressin with Intranasal placebo (2 arms). Primary endpoint: Changes in neural brain activity during social inclusion vs. exclusion. Started Jan 2015; status: completed.
02
Drugs
vasopressin
Beyond the preview
Go deeper on NCT02394054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02394054.